141 related articles for article (PubMed ID: 18520431)
21. Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.
Pérez M; Tůma I; Pytela O; Kadlecová E; Zemanová M; Lenderová Z
Eur Psychiatry; 2006 Dec; 21(8):548-50. PubMed ID: 16797936
[TBL] [Abstract][Full Text] [Related]
22. Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.
Crane PK; Doody RS
Neurology; 2009 Nov; 73(18):1514-5; author reply 1515-6. PubMed ID: 19884584
[No Abstract] [Full Text] [Related]
23. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P
J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422
[No Abstract] [Full Text] [Related]
24. Mild cognitive impairment: a treatment at last?
Allain H; Bentué-Ferrer D; Akwa Y
Lancet Neurol; 2004 Nov; 3(11):643. PubMed ID: 15488455
[No Abstract] [Full Text] [Related]
25. Mild cognitive impairment: to treat or not to treat.
Kirshner HS
Curr Neurol Neurosci Rep; 2005 Nov; 5(6):455-7. PubMed ID: 16263056
[TBL] [Abstract][Full Text] [Related]
26. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
[TBL] [Abstract][Full Text] [Related]
27. The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes.
Walker W; Seel R; Gibellato M; Lew H; Cornis-Pop M; Jena T; Silver T
Brain Inj; 2004 Aug; 18(8):739-50. PubMed ID: 15204315
[TBL] [Abstract][Full Text] [Related]
28. When the drugs don't work.
Logan A
Br J Gen Pract; 2005 Aug; 55(517):639. PubMed ID: 16105378
[No Abstract] [Full Text] [Related]
29. Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression.
Suda S; Sugihara G; Suyama R; Mori N; Takei N
J Clin Psychiatry; 2010 Jun; 71(6):806-8. PubMed ID: 20573331
[No Abstract] [Full Text] [Related]
30. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
[No Abstract] [Full Text] [Related]
31. Effects of donepezil on cognitive functioning in Down syndrome.
Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
[TBL] [Abstract][Full Text] [Related]
32. Donepezil in the treatment of progressive supranuclear palsy.
Fabbrini G; Barbanti P; Bonifati V; Colosimo C; Gasparini M; Vanacore N; Meco G
Acta Neurol Scand; 2001 Feb; 103(2):123-5. PubMed ID: 11227131
[TBL] [Abstract][Full Text] [Related]
33. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
Lee BJ; Lee JG; Kim YH
J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
[TBL] [Abstract][Full Text] [Related]
34. Donepezil improves symptoms of delirium in dementia: implications for future research.
Wengel SP; Roccaforte WH; Burke WJ
J Geriatr Psychiatry Neurol; 1998; 11(3):159-61. PubMed ID: 9894735
[TBL] [Abstract][Full Text] [Related]
35. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury.
Kaye NS; Townsend JB; Ivins R
J Neuropsychiatry Clin Neurosci; 2003; 15(3):383-4; author reply 384-5. PubMed ID: 12928519
[No Abstract] [Full Text] [Related]
36. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.
Tenovuo O
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):61-7. PubMed ID: 15610946
[TBL] [Abstract][Full Text] [Related]
37. Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil.
Kondoh T; Amamoto N; Doi T; Hamada H; Ogawa Y; Nakashima M; Sasaki H; Aikawa K; Tanaka T; Aoki M; Harada J; Moriuchi H
Ann Pharmacother; 2005 Mar; 39(3):563-6. PubMed ID: 15701776
[TBL] [Abstract][Full Text] [Related]
38. [Practical clinical use of therapeutic agents for Alzheimer's disease].
Arai T
Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):494-8. PubMed ID: 18079601
[No Abstract] [Full Text] [Related]
39. Vitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ;
N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527
[TBL] [Abstract][Full Text] [Related]
40. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
